APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nonstructural Protein 4B

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nonstructural Protein 4B Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchNonstructural Protein 4B Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Nonstructural Protein 4B Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Nonstructural Protein 4B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nonstructural Protein 4B Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Nonstructural Protein 4B Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Nonstructural Protein 4B market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nonstructural Protein 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nonstructural Protein 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nonstructural Protein 4B is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nonstructural Protein 4B market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nonstructural Protein 4B market include Johnson & Johnson, Merck & Co., Inc., GlaxoSmithKline Plc, Inovio Pharmaceuticals, Inc. and Gilead Sciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Nonstructural Protein 4B market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nonstructural Protein 4B and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nonstructural Protein 4B revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Nonstructural Protein 4B market.

Nonstructural Protein 4B Segment by Company

Johnson & Johnson

Merck & Co., Inc.

GlaxoSmithKline Plc

Inovio Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Nonstructural Protein 4B Segment by Type

GSK-8853

INO-8000

PTC-725

RL-15A

Others

Nonstructural Protein 4B Segment by Application

Hospital

Clinic

Others

Nonstructural Protein 4B Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nonstructural Protein 4B status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Nonstructural Protein 4B key companies, revenue, market share, and recent developments.

3. To split the Nonstructural Protein 4B breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Nonstructural Protein 4B market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nonstructural Protein 4B significant trends, drivers, influence factors in global and regions.

6. To analyze Nonstructural Protein 4B competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nonstructural Protein 4B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nonstructural Protein 4B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nonstructural Protein 4B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nonstructural Protein 4B industry.

Chapter 3: Detailed analysis of Nonstructural Protein 4B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Nonstructural Protein 4B in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Nonstructural Protein 4B in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nonstructural Protein 4B Industry Trends Table 2. Nonstructural Protein 4B Industry Drivers Table 3. Nonstructural Protein 4B Industry Opportunities and Challenges Table 4. Nonstructural Protein 4B Industry Restraints Table 5. Global Nonstructural Protein 4B Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nonstructural Protein 4B Revenue Share by Company (2021-2026) Table 7. Global Nonstructural Protein 4B Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Nonstructural Protein 4B Key Company Manufacturing Base & Headquarters Table 9. Global Nonstructural Protein 4B Company, Product Type & Application Table 10. Global Nonstructural Protein 4B Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Nonstructural Protein 4B by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of GSK-8853 Table 15. Significant Companies of INO-8000 Table 16. Significant Companies of PTC-725 Table 17. Significant Companies of RL-15A Table 18. Significant Companies of Others Table 19. Global Nonstructural Protein 4B Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Nonstructural Protein 4B Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Nonstructural Protein 4B Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Nonstructural Protein 4B Sales Value Share by Type (2021-2026) Table 23. Global Nonstructural Protein 4B Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Others Table 27. Global Nonstructural Protein 4B Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Nonstructural Protein 4B Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Nonstructural Protein 4B Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Nonstructural Protein 4B Sales Value Share by Application (2021-2026) Table 31. Global Nonstructural Protein 4B Sales Value Share by Application (2027-2032) Table 32. Global Nonstructural Protein 4B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Nonstructural Protein 4B Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Nonstructural Protein 4B Sales Value Share by Region (2021-2026) Table 35. Global Nonstructural Protein 4B Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Nonstructural Protein 4B Sales Value Share by Region (2027-2032) Table 37. Global Nonstructural Protein 4B Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nonstructural Protein 4B Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Nonstructural Protein 4B Sales Value Market Share by Country (2021-2026) Table 40. Global Nonstructural Protein 4B Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Nonstructural Protein 4B Sales Value Market Share by Country (2027-2032) Table 42. Johnson & Johnson Company Information Table 43. Johnson & Johnson Business Overview Table 44. Johnson & Johnson Nonstructural Protein 4B Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Johnson & Johnson Nonstructural Protein 4B Product Portfolio Table 46. Johnson & Johnson Recent Development Table 47. Merck & Co., Inc. Company Information Table 48. Merck & Co., Inc. Business Overview Table 49. Merck & Co., Inc. Nonstructural Protein 4B Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Merck & Co., Inc. Nonstructural Protein 4B Product Portfolio Table 51. Merck & Co., Inc. Recent Development Table 52. GlaxoSmithKline Plc Company Information Table 53. GlaxoSmithKline Plc Business Overview Table 54. GlaxoSmithKline Plc Nonstructural Protein 4B Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. GlaxoSmithKline Plc Nonstructural Protein 4B Product Portfolio Table 56. GlaxoSmithKline Plc Recent Development Table 57. Inovio Pharmaceuticals, Inc. Company Information Table 58. Inovio Pharmaceuticals, Inc. Business Overview Table 59. Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Product Portfolio Table 61. Inovio Pharmaceuticals, Inc. Recent Development Table 62. Gilead Sciences, Inc. Company Information Table 63. Gilead Sciences, Inc. Business Overview Table 64. Gilead Sciences, Inc. Nonstructural Protein 4B Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Gilead Sciences, Inc. Nonstructural Protein 4B Product Portfolio Table 66. Gilead Sciences, Inc. Recent Development Table 67. Research Programs/Design for This Report Table 68. Authors List of This Report Table 69. Secondary Sources Table 70. Primary Sources List of Figures Figure 1. Nonstructural Protein 4B Product Image Figure 2. Global Nonstructural Protein 4B Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nonstructural Protein 4B Market Size (2021-2032) & (US$ Million) Figure 4. Global Nonstructural Protein 4B Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. GSK-8853 Image Figure 8. INO-8000 Image Figure 9. PTC-725 Image Figure 10. RL-15A Image Figure 11. Others Image Figure 12. Global Nonstructural Protein 4B Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Nonstructural Protein 4B Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Nonstructural Protein 4B Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Nonstructural Protein 4B Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Nonstructural Protein 4B Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Nonstructural Protein 4B Sales Value Share by Application (2021-2032) Figure 21. Global Nonstructural Protein 4B Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Nonstructural Protein 4B Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Nonstructural Protein 4B Sales Value (2021-2032) & (US$ Million) Figure 24. North America Nonstructural Protein 4B Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Nonstructural Protein 4B Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Nonstructural Protein 4B Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Nonstructural Protein 4B Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Nonstructural Protein 4B Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Nonstructural Protein 4B Sales Value (2021-2032) & (US$ Million) Figure 30. South America Nonstructural Protein 4B Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Nonstructural Protein 4B Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Nonstructural Protein 4B Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Nonstructural Protein 4B Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • GSK-8853
  • INO-8000
  • PTC-725
  • RL-15A
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Johnson & Johnson
  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Inovio Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nonstructural Protein 4B Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nonstructural Protein 4B Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Nonstructural Protein 4B Market Dynamics
  1. 2.1 Nonstructural Protein 4B Industry Trends
  2. 2.2 Nonstructural Protein 4B Industry Drivers
  3. 2.3 Nonstructural Protein 4B Industry Opportunities and Challenges
  4. 2.4 Nonstructural Protein 4B Industry Restraints
3 Nonstructural Protein 4B Market by Company
  1. 3.1 Global Nonstructural Protein 4B Company Revenue Ranking in 2025
  2. 3.2 Global Nonstructural Protein 4B Revenue by Company (2021-2026)
  3. 3.3 Global Nonstructural Protein 4B Company Ranking (2024-2026)
  4. 3.4 Global Nonstructural Protein 4B Company Manufacturing Base and Headquarters
  5. 3.5 Global Nonstructural Protein 4B Company Product Type and Application
  6. 3.6 Global Nonstructural Protein 4B Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Nonstructural Protein 4B Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Nonstructural Protein 4B Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Nonstructural Protein 4B Market by Type
  1. 4.1 Nonstructural Protein 4B Type Introduction
  2. 4.1.1 GSK-8853
  3. 4.1.2 INO-8000
  4. 4.1.3 PTC-725
  5. 4.1.4 RL-15A
  6. 4.1.5 Others
  7. 4.2 Global Nonstructural Protein 4B Sales Value by Type
  8. 4.2.1 Global Nonstructural Protein 4B Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Nonstructural Protein 4B Sales Value by Type (2021-2032)
  10. 4.2.3 Global Nonstructural Protein 4B Sales Value Share by Type (2021-2032)
5 Nonstructural Protein 4B Market by Application
  1. 5.1 Nonstructural Protein 4B Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Nonstructural Protein 4B Sales Value by Application
  6. 5.2.1 Global Nonstructural Protein 4B Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nonstructural Protein 4B Sales Value by Application (2021-2032)
  8. 5.2.3 Global Nonstructural Protein 4B Sales Value Share by Application (2021-2032)
6 Nonstructural Protein 4B Regional Value Analysis
  1. 6.1 Global Nonstructural Protein 4B Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nonstructural Protein 4B Sales Value by Region (2021-2032)
  3. 6.2.1 Global Nonstructural Protein 4B Sales Value by Region: 2021-2026
  4. 6.2.2 Global Nonstructural Protein 4B Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nonstructural Protein 4B Sales Value (2021-2032)
  7. 6.3.2 North America Nonstructural Protein 4B Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Nonstructural Protein 4B Sales Value (2021-2032)
  10. 6.4.2 Europe Nonstructural Protein 4B Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Nonstructural Protein 4B Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Nonstructural Protein 4B Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Nonstructural Protein 4B Sales Value (2021-2032)
  16. 6.6.2 South America Nonstructural Protein 4B Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Nonstructural Protein 4B Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Nonstructural Protein 4B Sales Value Share by Country, 2025 VS 2032
7 Nonstructural Protein 4B Country-level Value Analysis
  1. 7.1 Global Nonstructural Protein 4B Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nonstructural Protein 4B Sales Value by Country (2021-2032)
  3. 7.2.1 Global Nonstructural Protein 4B Sales Value by Country (2021-2026)
  4. 7.2.2 Global Nonstructural Protein 4B Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Nonstructural Protein 4B Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Nonstructural Protein 4B Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Nonstructural Protein 4B Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Nonstructural Protein 4B Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Nonstructural Protein 4B Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Merck & Co., Inc.
  8. 8.2.1 Merck & Co., Inc. Company Information
  9. 8.2.2 Merck & Co., Inc. Business Overview
  10. 8.2.3 Merck & Co., Inc. Nonstructural Protein 4B Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck & Co., Inc. Nonstructural Protein 4B Product Portfolio
  12. 8.2.5 Merck & Co., Inc. Recent Developments
  13. 8.3 GlaxoSmithKline Plc
  14. 8.3.1 GlaxoSmithKline Plc Company Information
  15. 8.3.2 GlaxoSmithKline Plc Business Overview
  16. 8.3.3 GlaxoSmithKline Plc Nonstructural Protein 4B Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Plc Nonstructural Protein 4B Product Portfolio
  18. 8.3.5 GlaxoSmithKline Plc Recent Developments
  19. 8.4 Inovio Pharmaceuticals, Inc.
  20. 8.4.1 Inovio Pharmaceuticals, Inc. Company Information
  21. 8.4.2 Inovio Pharmaceuticals, Inc. Business Overview
  22. 8.4.3 Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Inovio Pharmaceuticals, Inc. Nonstructural Protein 4B Product Portfolio
  24. 8.4.5 Inovio Pharmaceuticals, Inc. Recent Developments
  25. 8.5 Gilead Sciences, Inc.
  26. 8.5.1 Gilead Sciences, Inc. Company Information
  27. 8.5.2 Gilead Sciences, Inc. Business Overview
  28. 8.5.3 Gilead Sciences, Inc. Nonstructural Protein 4B Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Gilead Sciences, Inc. Nonstructural Protein 4B Product Portfolio
  30. 8.5.5 Gilead Sciences, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst